EMCURE PHARMACEUTICALS L Share Price

₹ 1,966.80

+₹83.30 (4.42%)
1D
Last updated 03 Nov, 2026, 15:29 IST
NSE: EMCURE
|
Pharmaceuticals

EMCURE PHARMACEUTICALS L Share Price Today

As of 3 Nov 2026, EMCURE PHARMACEUTICALS L share price is ₹1,966.80. The stock opened at ₹1,899.00, compared to its previous close of ₹1,883.50. During today's trading session, EMCURE PHARMACEUTICALS L share price moved in the range of ₹1,882.50 to ₹2,071.80, with an average price of ₹1,977.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,306.50 and a high of ₹2,100.70. On the performance front, EMCURE PHARMACEUTICALS L share price has increased by 12.11% over the last six months and is up 42.81% on a year-on-year basis.

Share price over the last 1 day rose from 1907.80 to 1966.80, ranging between 1886.90 and 2064.40.
₹1,882.50
4.42% up today
₹2,071.80
1D LOW
1D HIGH

EMCURE PHARMACEUTICALS L Stock Insights

Latest Earning
Op Profit TrendUp by 15.34% QoQ
Latest Earning
Net Profit TrendUp by 20.00% QoQ
Latest Earning
Revenue TrendUp by 4.40% QoQ
Stock Performance
OutperformingBeat Nifty by 0.96 % in last 3 month
Shareholding Pattern
PromoterPromoter decreased stake by 0.02%
Shareholding Pattern
DIIDII decreased stake by 9.97%
Shareholding Pattern
FIIFII increased stake by 1.38%
EMCURE PHARMACEUTICALS L stock performance
Open₹1,899.00
High₹2,071.80
Low₹1,882.50
Prev. close₹1,883.50
EMCURE PHARMACEUTICALS L trading activity
Volume10,05,828
Average traded price₹1,995.85
Last traded time03:29:58 03 Nov
Last traded quantity2
Circuit
L
H
₹1,695.20
₹2,071.80
52-week
L
H
₹1,306.50
₹2,100.70
Mkt Cap Cr
35,439.85
P/E
35.05
P/B
7.21
ROA
10.6%
ROE
18.67%
ROCE
21.76%
Quick Ratio
0.82
EV/EBITDA
18.79

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
Emcure Pharma has underperformed the market
Valuation: 2 out of 5, Expensive
Valuation
Expensive
Emcure Pharma PE is significantly higher than its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Emcure Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4826.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

EMCURE PHARMACEUTICALS L Company Background

ISIN
INE168P01015
Sector Market Cap
₹ 35,439.85 Cr

Emcure Pharmaceuticals Limited is an India-based pharmaceutical company, which is engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several major therapeutic areas. It offers a range of products and services under formulations, biologics and APIs. It operates across a wide scope of areas, including gynecological, cardiology, antivirals, vitamins, pain/analgesics, anti-neoplastic, diabetes, anti-infective, respiratory, CNS and nephrology. Its brands include OROFER (Gynecological), BEVON (Vitamins), ZOSTUM (Anti- infectives), Ferium (Gynecological), EXHEP (Cardiovascular), Maxtra (Respiratory) and Pause (Blood-Related). Its API products include S-Amlodipine, Dydrogesterone, Ferric Carboxymaltose, Ferrous Ascorbate and Eribulin. Its biologics business offers various products, including Elaxim (cardiology), Vintor (nephrology), Xgrast (anti-neoplastic) and Pegex (anti- neoplastic). It has developed two platforms: Mammalian and Microbial.

EMCURE PHARMACEUTICALS L Financial Highlights

  • Revenue: EMCURE PHARMACEUTICALS L reported revenue of ₹9,216.20 crore in FY26 vs ₹7,963.26 crore in FY25. It showed an increase of 15.73% on a yearly basis.
  • Operating Profit: EMCURE PHARMACEUTICALS L reported an operating profit of ₹1,287.14 crore in FY26 vs ₹971.35 crore in FY25. It showed an increase of 32.51% on a year-on-year basis.
  • Net Profit: EMCURE PHARMACEUTICALS L reported a net profit of ₹941.27 crore in FY26 vs ₹707.47 crore in FY25. It showed an increase of 33.05% on a yearly basis.

EMCURE PHARMACEUTICALS L Quarterly Result Highlights

  • EMCURE PHARMACEUTICALS L reported revenue of ₹2,582.52 crore in Jun 2026, compared with ₹2,473.69 crore in Mar 2026, representing an increase of 4.40% on a quarter-on-quarter (QoQ) basis.
  • EMCURE PHARMACEUTICALS L reported an operating profit of ₹393.53 crore in Jun 2026, compared with ₹341.18 crore in Mar 2026, representing an increase of 15.34% on a quarter-on-quarter (QoQ) basis.
  • EMCURE PHARMACEUTICALS L reported a profit of ₹292.49 crore in Jun 2026, compared with ₹243.74 crore in Mar 2026, reflecting an increase of 20.00% on a QoQ basis.
  • The earnings per share (EPS) of EMCURE PHARMACEUTICALS L stood at ₹48.77 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
77.82%
FII
4.94%
Other DII
1.44%
Retail and other
8.75%
Mutual funds
7.05%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20253.59%
Mar 20263.35%
Jun 20264.88%
Sep 20264.94%

EMCURE PHARMACEUTICALS L Investment Returns

1 day
+0.63%
1 week
+5.80%
1 month
-3.14%
1 year
+42.81%
3 years
+38.58%
5 years
+38.58%

EMCURE PHARMACEUTICALS L Share Price History

EMCURE PHARMACEUTICALS L share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹1,891.30 / ₹1,883.50
+0.63%
30 Oct 26
₹1,858.10 / ₹1,871.80
+0.36%
29 Oct 26
₹1,875.00 / ₹1,865.00
-0.53%
28 Oct 26
₹1,875.70 / ₹1,875.00
-0.01%
Show more

EMCURE PHARMACEUTICALS L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹9,203.54₹7,896.00₹6,658.25₹5,985.81
Other Income₹131.47₹72.79₹56.99₹45.91
Total Revenue₹9,335.01₹7,968.78₹6,715.24₹6,031.72
Total Expenses₹8,016.52₹6,987.06₹5,978.08₹5,278.36
Profit Before Tax₹1,287.14₹971.35₹727.23₹747.22
Tax₹345.87₹263.88₹199.65₹185.37
Profit After Tax₹941.27₹707.47₹527.58₹561.85
EPS - Basic₹48.77₹36.43₹27.54₹29.42
EPS - Diluted₹48.77₹36.43₹27.54₹29.42

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1,287.14₹971.35₹727.23₹747.22
Income before WC changes₹1,841.76₹1,522.86₹1,270.38₹1,239.56
Change in Assets-₹913.59-₹599.85-₹166.98-₹277.81
Change in Liabilities₹383.45₹175.56₹217.49-₹14.42
Change in WC-₹530.13-₹424.30₹50.52-₹292.24
Cash flow from Operations₹943.55₹851.71₹1,097.24₹746.85
Cash flow from Investing-₹1,193.06-₹94.00-₹712.51-₹467.69
Cash flow from Financing₹343.43-₹813.96-₹164.21-₹145.40
Total Cash Flow₹93.92-₹56.25₹220.52₹133.77
Cash (Start of the year)-₹14.31₹43.99-₹174.53-₹308.17
Cash (End of the year)₹97.77-₹14.31₹43.99-₹174.53

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹4,000.38₹3,676.86₹3,546.25₹2,836.62
Current Assets₹5,612.10₹4,555.86₹4,259.92₹3,835.91
Total Assets₹9,612.48₹8,232.72₹7,806.16₹6,672.53
Current Liabilities₹3,912.24₹2,668.27₹3,210.47₹3,019.19
Net Current Asset₹1,699.86₹1,887.59₹1,049.44₹816.72
Non-Current Liabilities₹723.57₹922.90₹1,473.93₹1,003.68
Equity Capital₹4,976.67₹4,641.55₹3,121.77₹2,649.66
Total Equity & Liabilities₹9,612.48₹8,232.72₹7,806.16₹6,672.53

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹5,243.19₹4,381.92₹3,497.66₹3,107.09
Other Income₹311.66₹142.48₹138.26₹125.35
Total Revenue₹5,554.84₹4,524.40₹3,635.91₹3,232.44
Total Expenses₹4,585.58₹4,096.69₹3,426.69₹3,013.95
Profit Before Tax₹944.19₹427.71₹199.91₹212.34
Tax₹211.23₹110.58₹39.08₹52.28
Profit After Tax₹732.96₹317.13₹160.83₹160.06
EPS - Basic₹38.67₹16.95₹8.89₹8.85
EPS - Diluted₹38.67₹16.95₹8.89₹8.85

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹944.19₹427.71₹199.91₹212.34
Income before WC changes₹1,165.46₹711.85₹525.47₹521.55
Change in Assets-₹583.04-₹368.39-₹91.66-₹22.13
Change in Liabilities₹58.55₹280.94₹218.02₹90.49
Change in WC-₹524.49-₹87.45₹126.36₹68.37
Cash flow from Operations₹423.56₹558.29₹584.97₹505.37
Cash flow from Investing-₹948.10-₹435.61-₹171.08-₹270.44
Cash flow from Financing₹525.76-₹49.25-₹287.75-₹54.52
Total Cash Flow₹1.22₹73.43₹126.15₹180.42
Cash (Start of the year)-₹17.53-₹88.91-₹213.05-₹393.35
Cash (End of the year)-₹15.02-₹17.53-₹88.91-₹213.05

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹3,872.98₹2,956.06₹2,633.50₹2,456.44
Current Assets₹3,041.07₹2,460.05₹2,123.43₹2,159.41
Total Assets₹6,914.04₹5,416.11₹4,756.93₹4,615.85
Current Liabilities₹2,267.42₹1,719.16₹2,130.12₹1,996.33
Net Current Asset₹773.65₹740.89-₹6.68₹163.07
Non-Current Liabilities₹936.03₹672.59₹691.72₹777.65
Equity Capital₹3,710.60₹3,024.36₹1,935.10₹1,841.87
Total Equity & Liabilities₹6,914.04₹5,416.11₹4,756.93₹4,615.85
* All values are in INR Crore
EMCURE PHARMACEUTICALS L market depth
Bid quantityBid priceAsk priceAsk quantity
001976.6174
0000
0000
0000
0000
Total bid quantity0
Total ask quantity174
EMCURE PHARMACEUTICALS L technical summary
Bearish indicators4
Neutral indicators3
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
53.43
Neutral
ATR (14)
56.46
Neutral
STOCH(9,6)
91.08
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
28.25
Bearish
UO(9)
63.48
Neutral
ROC(12)
0.93
Bullish
WillR(14)
-8.92
Bearish
Period
Simple value
Exponential vaue
5D
1874.1
1863.64
10D
1822.54
1850.25
20D
1847.33
1856.71
50D
1890.68
1874.31
100D
1874.35
1843.09
Volume trend — traded volume by day
3 Nov10L
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct1L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

EMCURE PHARMACEUTICALS L
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in EMCURE PHARMACEUTICALS L

Fund name
AUM
Bajaj Finserv Healthcare Fund
3.79%
Aditya Birla Sun Life Pharma & Healthcare Fund
3.03%
Baroda BNP Paribas Health and Wellness Fund
2.80%

EMCURE PHARMACEUTICALS L Returns Calculator

Ex-date: 04 Sep 2026

EMCURE PHARMACEUTICALS L Latest News

2hr ago
Emcure Pharma Q2 FY27 results: Net profit jumps 34% YoY; domestic business revenue increases to ₹1,155 crore
2 months ago
Urban Company, Cupid, Acme Solar, among other stocks in focus on FTSE index addition update; key things to know
2 months ago
Emcure Pharma Q1 results: Profit jumps 42% YoY to ₹294 crore, revenue climbs 23%; check key numbers
3 months ago
Emcure Pharmaceuticals shares in spotlight on receiving CDSCO approval to market Poviztra for fatty liver treatment
4 months ago
Emcure Pharmaceuticals shares rise nearly 4% after Bain Capital divests 2% stake; everything you need to know
4 months ago
Stocks to watch, June 10: Afcons Infra, NLC India, Ajanta Pharma, Emcure Pharma, Adani Green, oil-sensitives
6 months ago
Emcure Pharmaceuticals Q4 results: Net profit climbs 29% YoY to ₹243 crore; ₹3.6/share dividend recommended
Showing news item 1 of 7

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

EMCURE PHARMACEUTICALS L Share Price FAQs

Please be aware that EMCURE PHARMACEUTICALS L stock prices are subject to continuous fluctuations due to various factors.